{"created":"2023-05-15T09:04:03.281682+00:00","id":1144,"links":{},"metadata":{"_buckets":{"deposit":"f231ea96-d6d4-4065-8701-09c9112e84ab"},"_deposit":{"created_by":12,"id":"1144","owners":[12],"pid":{"revision_id":0,"type":"depid","value":"1144"},"status":"published"},"_oai":{"id":"oai:fujita-hu.repo.nii.ac.jp:00001144","sets":["63:132:177"]},"author_link":["3573"],"item_10006_alternative_title_1":{"attribute_name":"タイトル(別言語)","attribute_value_mlt":[{"subitem_alternative_title":"日本と英国におけるHLAバリアントを基盤とした薬理ゲノム学ガイド下でのクロザピン投与管理方法の費用効果","subitem_alternative_title_language":"ja"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2021-09-30"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"藤田医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"33916","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(医学)","subitem_degreename_language":"ja"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第1281号"}]},"item_10006_relation_16":{"attribute_name":"掲載誌情報","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_language":"en","subitem_relation_name_text":"Transl Psychiatry. 2021 Jul 7;11(1):362."}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1038/s41398-021-01487-4","subitem_relation_type_select":"DOI"}}]},"item_10006_rights_31":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Creative Commons Attribution 4.0 International","subitem_rights_language":"en","subitem_rights_resource":"https://creativecommons.org/licenses/by/4.0/"}]},"item_10006_version_type_18":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Ninomiya, Kohei","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"3573","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-12-29"}],"displaytype":"simple","filename":"甲1281_要旨.pdf","filesize":[{"value":"513.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"要旨","objectType":"abstract","url":"https://fujita-hu.repo.nii.ac.jp/record/1144/files/甲1281_要旨.pdf"},"version_id":"ed93b738-7cec-430a-95bc-1a9270ce2cb1"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-12-29"}],"displaytype":"simple","filename":"甲1281_本文.pdf","filesize":[{"value":"1.1 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://fujita-hu.repo.nii.ac.jp/record/1144/files/甲1281_本文.pdf"},"version_id":"e9ebe28f-3a45-4363-9922-5a4d5bbe734e"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"12","path":["177"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2021-12-29"},"publish_date":"2021-12-29","publish_status":"0","recid":"1144","relation_version_is_last":true,"title":["Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK"],"weko_creator_id":"12","weko_shared_id":-1},"updated":"2024-11-20T04:31:42.573622+00:00"}